{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:02:16Z","timestamp":1789736536163,"version":"4.0.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,12]]},"abstract":"<jats:p>Ustekinumab is prescribed for the treatment of patients with steroid-resistant moderate to severe Crohn\u2019s disease. We investigated its clinical outcome in patients with small and large intestinal lesions. Patients who were newly administered ustekinumab between March 2014 and December 2020 at Hamamatsu University Hospital were included in the study. The primary endpoint was Crohn\u2019s disease activity index score at baseline and weeks 8, 24, and 48 after the initiation of treatment, and secondary endpoints were albumin, hemoglobin, and C-reactive protein at these time points. Ustekinumab treatment retention was examined in both groups; the 2 groups were compared using the Friedman test, Mann\u2013Whitney <jats:italic toggle=\"yes\">U<\/jats:italic> test, or Fisher exact test. Overall, Crohn\u2019s disease activity index scores improved between baseline and 48 weeks, but the difference was not significant. However, there was a significant improvement between baseline and 48 weeks in patients with lesions in the small intestine only. Overall, patients showed significant improvement in albumin levels between baseline and 48 weeks but not in C-reactive protein or hemoglobin levels. When limited to patients with lesions in the small intestine, albumin and hemoglobin levels showed significant improvement. Both types showed high rates of treatment retention, although there was no significant difference. Ustekinumab appears to be a safe and effective treatment option that may be particularly effective in patients with lesions in the small intestine only.<\/jats:p>","DOI":"10.1097\/md.0000000000035647","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T19:02:12Z","timestamp":1712948532000},"page":"e35647","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Ustekinumab effectiveness in Crohn\u2019s disease with lesions in the intestines"],"prefix":"10.1097","volume":"103","author":[{"given":"Satoshi","family":"Tamura","sequence":"first","affiliation":[{"name":"First Department of Medicine, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Asai","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Ishida","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Miyazu","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Tani","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoko","family":"Yamade","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Hamaya","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moriya","family":"Iwaizumi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Osawa","sequence":"additional","affiliation":[{"name":"Department of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Furuta","sequence":"additional","affiliation":[{"name":"Center for Clinical Research, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-1097","authenticated-orcid":false,"given":"Ken","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn\u2019s disease.","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease.","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease.","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat Immunol"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/ecco-jcc\/jjaa083","article-title":"Intestinal CD14+ macrophages protect CD4+ T cells from activation-induced cell death via exosomal membrane TNF in Crohn\u2019s disease.","volume":"14","author":"Liu","year":"2020","journal-title":"J Crohns Colitis"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/gutjnl-2017-315671","article-title":"Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn\u2019s disease.","volume":"68","author":"Schmitt","year":"2019","journal-title":"Gut"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.crohns.2011.10.010","article-title":"Profiles of circulating cytokines in patients with Crohn\u2019s disease under maintenance therapy with infliximab.","volume":"6","author":"Ogawa","year":"2012","journal-title":"J Crohns Colitis"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease.","volume":"375","author":"Feagan","year":"2016","journal-title":"N Engl J Med"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target.","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system.","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cgh.2021.02.025","article-title":"Five-year efficacy and safety of ustekinumab treatment in Crohn\u2019s disease: the IM-UNITI Trial.","volume":"20","author":"Sandborn","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/apt.16410","article-title":"Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study.","volume":"54","author":"Meyer","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/vaccines9121471","article-title":"Serological response to BNT162b2 and ChAdOx1 nCoV-19 vaccines in patients with inflammatory bowel disease on biologic therapies.","volume":"9","author":"Shehab","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cgh.2019.08.024","article-title":"Small bowel healing detected by endoscopy in patients with Crohn\u2019s disease after treatment with antibodies against tumor necrosis factor.","volume":"18","author":"Takenaka","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"134","DOI":"10.14309\/ajg.0000000000000834","article-title":"Location but not severity of endoscopic lesions influences endoscopic remission rates in Crohn\u2019s disease: a post hoc analysis of TAILORIX.","volume":"116","author":"Rivi\u00e8re","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1053\/j.gastro.2018.05.028","article-title":"Abnormal small intestinal epithelial microvilli in patients with Crohn\u2019s disease.","volume":"155","author":"VanDussen","year":"2018","journal-title":"Gastroenterology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T16:02:36Z","timestamp":1750262556000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":15,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035647","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,12]]}}}